SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Emmaus Medical, Inc. CEO Yutaka Niihara, M.D., Issues Statement in Connection With Status of Company's Phase III FDA Sickle Cell Treatment Trials